Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medical Facilities Corp T.DR

Alternate Symbol(s):  MFCSF

Medical Facilities Corporation is a Canada-based company, which owns a diverse portfolio of surgical facilities in the United States. The Company owns interest in four specialty surgical hospitals (SSHs) located in Arkansas, Oklahoma, and South Dakota, and one ambulatory surgery centers (ASC) located in California. ASCs are specialized surgical centers that only provide outpatient procedures, whereas SSHs are licensed for both inpatient and outpatient surgeries. The SSHs and ASC provide facilities, including staffing, surgical materials and supplies, and other support necessary for scheduled surgical, pain management, imaging, and diagnostic procedures. In addition, two of the SSHs provide urgent care services. The Company's subsidiaries include Arkansas Surgical Hospital, LLC, Oklahoma Spine Hospital, LLC, Black Hills Surgical Hospital, LLP, Sioux Falls Specialty Hospital, LLP, and The Surgery Center of Newport Coast.


TSX:DR - Post by User

Post by nozzpackon Aug 26, 2020 10:39am
222 Views
Post# 31455134

Other Considerations of Fair Value

Other Considerations of Fair ValueThe Ebitda multiple is another way to value DR.

I provide data for the last 3 years along with net debt ( cash less LT debt )

Year                  Ebitda          EV              EV/Ebitda           net debt 

2017                  $94.6 m     $551 m         5.8                      $9 m
2018                  $99.0 m     $518 m         5.2                      $25 m
2019                  $96.2 m     $419 m         4.4                      $35 m
2020( H1 x 2 )   $86.2m      $125 m         1.5                      $-11 m

DR has the best balance sheet in its recent history and with the sale of low margin assets, has very robust operating margins.

The average EV to Ebitda for recent years is 4.8.

DR is currently trading at just 1.5 times, which suggests a 3 fold increase from current levels by exit 2020................ approx $13 per share
<< Previous
Bullboard Posts
Next >>